Seismic Therapeutic
Ishan Sharma began their career in 2013 as a Research Assistant at Shire Pharmaceuticals. In 2014, they moved to Cell Signaling Technology (CST) as a Research Associate. From 2017 to 2022, they worked at Acceleron Pharma, first as an Associate Scientist-I and then as a Research Associate II. Ishan currently holds the role of Senior Associate Scientist II at Seismic Therapeutic.
Ishan Sharma's education history includes a Bachelor of Applied Science (B.A.Sc.) in Biochemistry from Northeastern University, which they completed between 2011 and 2014. Ishan also holds an Associate's degree in Biochemistry and Molecular Biology from Bunkerhill Community College, which they received between 2009 and 2011. Ishan is currently pursuing two Master's degrees in Biotechnology from Harvard University.
Seismic Therapeutic
1 followers
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.